|
|
| Name of Committee | Circulatory System Devices Panel |
| Date and Time | The meeting was held on the following dates:
Sep 19, 2007 8:00 AM - 6:00 PM
Sep 20, 2007 8:00 AM - 6:00 PM
|
| Location | Hilton Washington DC North/Gaithersburg, Salons A, B and C
620 Perry Parkway,
Gaithersburg
, MD |
| Contact Information | James Swink, Center for Devices and Radiological Health (HFZ-450), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-4179, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512625. Please call the Information Line for up-to-date information on this meeting. A notice in the FEDERAL REGISTER about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. |
| Agenda | On September 19, 2007, the committee will discuss, make recommendations and vote on a premarket approval application, sponsored by SyntheMed, Inc., for the REPEL-CV, which is a surgical adjuvant indicated for reducing the incidence, severity and extent of post-operative adhesion formation in patients undergoing cardiac surgery. On September 20, 2007, the committee will discuss and make recommendations regarding clinical trial designs for cardiac ablation devices designed to treat patients with medically refractory atrial fibrillation. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on the year 2007 and scroll down to the appropriate advisory committee link. |
| Procedure | Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before September 5, 2007. Oral presentations from the public will be scheduled for approximately 30 minutes at the beginning of committee deliberations on each day and for approximately 30 minutes near the end of the deliberations on each day. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before August 28, 2007. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by August 29, 2007. |
| | Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. |
| Conduct | FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/ for procedures on public conduct during advisory committee meetings. |
| Related Documents |
| Agenda: | Agenda for September 19, 2007 |  |
| Agenda: | Draft Agenda for September 20, 2007 Meeting | |
| Brief Summary: | Summary from the Circulatory System Devices Panel Meeting - September 19, 2007 |  |
| Brief Summary: | Summary from the Circulatory System Devices Panel Meeting - September 20, 2007 | |
| Briefing: | Briefing Information for September 20, 2007 Meeting | |
| Briefing: | Briefing Information for September 19, 2007 | |
| Notice of Meeting: | Notice of Meeting on September 19 & 20, 2007 | |
| Other: | Nature and Basis Statements of Conflict(s) of Interest for September 19 & 20, 2007 Meeting | |
| Questions: | Questions for September 19 and 20, 2007 | |
| Questions: | OPH Questions to the Panel | |
| Questions: | Draft Questions for September 20, 2007 Meeting | |
| Roster: | Final Roster for September 19, 2007 | |
| Roster: | Final Roster for September 20, 2007 | |
| Roster: | Draft Roster for September 20, 2007 Meeting | |
| Roster: | Roster for September 19, 2007 | |
| Slides: | Slides for September 19 and 20, 2007 | |
| Transcript: | September 19, Part 3 | |
| Transcript: | September 19, Part 1 | |
| Transcript: | September 19, Part 2 | |
| Transcript: | September 19, Part 4 | |
| Transcript: | September 20, Part 1 | |
| Transcript: | September 20, Part 2 | |
| Transcript: | September 20, Part 3 | |
| Transcript: | September 20, Part 4 | |
| Transcript: | September 20, Part 5 | |
| Transcript: | September 20, Part 6 | |
|
| Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). |
|
